Secondary Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Recurrent Mucinous Ovarian Cancer (HI-MOC Study)
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Ohio State University Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center
Uppsala University
Hospices Civils de Lyon
Memorial Sloan Kettering Cancer Center
Maimónides Biomedical Research Institute of Córdoba
University of California, San Francisco
Wake Forest University Health Sciences
Columbia University
Banner Health
The First Affiliated Hospital of Guangzhou Medical University
The Netherlands Cancer Institute
The University of Hong Kong
The University of Hong Kong
Mayo Clinic
Mercy Medical Center
University of Chicago
University of California, San Diego
University Hospital, Ghent
University Hospital, Ghent
Cantonal Hospital of St. Gallen
Columbia University
Columbia University
Women's Hospital School Of Medicine Zhejiang University
Fudan University
Professor Fernando Figueira Integral Medicine Institute
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Nanfang Hospital, Southern Medical University
UMC Utrecht
University of Regensburg
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Masonic Cancer Center, University of Minnesota
Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia
Masonic Cancer Center, University of Minnesota
Memorial Sloan Kettering Cancer Center
University Hospital, Gasthuisberg
A.O. Ospedale Papa Giovanni XXIII
Eastern Hepatobiliary Surgery Hospital
M.D. Anderson Cancer Center
Uppsala University
Wuhan University